Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:05 PM
Ignite Modification Date:
2025-12-24 @ 12:05 PM
NCT ID:
NCT07229261
Eligibility Criteria:
Inclusion Criteria:
* Inpatient Cohort
* pregnant patients with a clinical diagnosis of preeclampsia with severe features
* gestational age between 23+0 and 32+0 weeks' gestation
* singleton pregnancy
* age 18-50 years old
* No indication for immediate delivery (e.g. the patient and their physician team have planned expectant management of preeclampsia with severe features
* Able to consent and follow a 2-step commend
* English speaking
* Outpatient Cohort
* Pregnant patients with a clinical diagnosis of preeclampsia without severe features
* gestational age between 23+0 and 34+0 weeks' gestation
* singleton pregnancy
* age 18-50 years old
* No indication for immediate delivery
* Planned outpatient management of preeclampsia
* Able to consent and follow a 2-step commend
* English speaking
Exclusion Criteria:
* • Unable to stand from chair without physical assistance from another person (able to use assistive device).
* History of blood clots in the extremities or any condition in which compression of the thigh or transient ischemia is contraindicated (i.e., wounds in the leg).
* Chronic lasting symptoms (\> 6 months) of severe COVID-19 (i.e., hospitalization)
* History of head trauma or concussion within the past 6 months
* Comorbid neurological disorder
* Peripheral vascular disease
* Diagnosed myocardial infarction or arrhythmia in the previous year
* Resting SBP ≥180 mmHg or DBP ≥ 100 mmHg
* Other significant medical condition likely to influence study or jeopardize safety as assessed by the Primary Investigator
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT07229261
Study Brief:
Protocol Section:
NCT07229261